Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 1, 1987
Coexpression of intermediate filament polypeptides in human fetal and adult tissuesG N Van Muijen, D J Ruiter, S O Warnaar
Human Pathology|June 1, 1985
Intermediate filaments in Merkel cell tumorsG N van Muijen, D J Ruiter, S O Warnaar
Cancer Research|January 1, 1980
Detection of antibodies cross-reactive with type C RNA tumor viral p30 protein in human sera and exudate fluidsP Herbrink, J E Moen, J Brouwer, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|September 1, 1988
An immunohistochemical study performed with monoclonal and polyclonal antibodies to mouse epidermal growth factorH J Beerstecher, C Huiskens-van der Meij, S O Warnaar
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 1, 1996
Target-specific activation of mast cells by immunoglobulin E reactive with a renal cell carcinoma-associated antigenR M Luiten, G J Fleuren, S O Warnaar, et al.
International Journal of Cancer|July 9, 1991
Localization of monoclonal antibody G250 and bispecific monoclonal antibody CD3/G250 in human renal-cell carcinoma xenografts: relative effects of size and affinityJ van Dijk, S T Zegveld, G J Fleuren, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|March 1, 1990
Expression of intermediate-sized filaments in developing and adult human kidney and in renal cell carcinomaE Oosterwijk, G N Van Muijen, J C Oosterwijk-Wakka, et al.
Cancer Research|April 15, 2000
The human antimouse immunoglobulin response and the anti-idiotypic network have no influence on clinical outcome in patients with minimal residual colorectal cancer treated with monoclonal antibody CO17-1AR Gruber, L J van Haarlem, S O Warnaar, et al.
Immunological Reviews|June 1, 1995
Tumor heterogeneity and immunotherapy of cancerG J Fleuren, A Gorter, P J Kuppen, et al.
International Journal of Cancer|October 23, 1997
Local but no systemic immunomodulation by intraperitoneal treatment of advanced ovarian cancer with autologous T lymphocytes re-targeted by a bi-specific monoclonal antibodyC H Lamers, R L Bolhuis, S O Warnaar, et al.
Pageof 7